| protein activation cascade | GO:0072376 | 19 | 0.786 | |
| metanephric glomerular visceral epithelial cell development | GO:0072249 | 2 | 0.765 | |
| regulation of cell activation | GO:0050865 | 289 | 0.634 | Human |
| metanephric glomerular epithelium development | GO:0072244 | 3 | 0.627 | |
| purinergic nucleotide receptor signaling pathway | GO:0035590 | 3 | 0.541 | |
| metanephric mesenchymal cell migration | GO:0035789 | 2 | 0.475 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.461 | |
| negative regulation of gluconeogenesis | GO:0045721 | 9 | 0.456 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.409 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.402 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.383 | Human |
| sequestering of metal ion | GO:0051238 | 19 | 0.345 | |
| regulation of type iia hypersensitivity | GO:0001796 | 4 | 0.337 | |
| immune effector process | GO:0002252 | 321 | 0.332 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.329 | |
| regulation of platelet derived growth factor receptor alpha signaling pathway | GO:2000583 | 2 | 0.314 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.308 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.295 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.292 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.288 | |
| cation transport | GO:0006812 | 399 | 0.280 | |
| metanephric glomerular epithelial cell development | GO:0072313 | 2 | 0.279 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.275 | |
| positive regulation of natural killer cell chemotaxis | GO:2000503 | 1 | 0.275 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.274 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.262 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.261 | Human |
| cellular homeostasis | GO:0019725 | 240 | 0.253 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.253 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.246 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.234 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.226 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.221 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.220 | |
| antigen processing and presentation of peptide antigen | GO:0048002 | 29 | 0.219 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.218 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.217 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.212 | |
| mapk cascade | GO:0000165 | 281 | 0.210 | |
| regulation of cell migration | GO:0030334 | 219 | 0.201 | Human Rat |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.193 | |
| positive regulation of granulocyte macrophage colony stimulating factor biosynthetic process | GO:0045425 | 2 | 0.191 | |
| calcium ion transport | GO:0006816 | 159 | 0.191 | |
| antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii | GO:0002504 | 17 | 0.189 | |
| amine metabolic process | GO:0009308 | 45 | 0.187 | |
| chemotaxis | GO:0006935 | 247 | 0.185 | Human |
| positive regulation of calcium mediated signaling | GO:0050850 | 15 | 0.179 | |
| cell migration involved in metanephros development | GO:0035788 | 2 | 0.173 | |
| antigen processing and presentation | GO:0019882 | 47 | 0.173 | |
| negative regulation of type i hypersensitivity | GO:0001811 | 1 | 0.171 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.162 | |
| cation homeostasis | GO:0055080 | 212 | 0.162 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.161 | Human |
| negative regulation of hypersensitivity | GO:0002884 | 3 | 0.161 | |
| detection of oxidative stress | GO:0070994 | 1 | 0.160 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.156 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.155 | |
| membrane organization | GO:0061024 | 245 | 0.154 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.154 | |
| metanephric glomerular visceral epithelial cell differentiation | GO:0072248 | 2 | 0.152 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.151 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.149 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.147 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.145 | |
| positive regulation of metanephric glomerular visceral epithelial cell development | GO:2000478 | 1 | 0.143 | |
| humoral immune response mediated by circulating immunoglobulin | GO:0002455 | 14 | 0.143 | |
| regulation of metanephric mesenchymal cell migration | GO:2000589 | 2 | 0.142 | |
| positive regulation of metanephric glomerulus development | GO:0072300 | 4 | 0.141 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.138 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.137 | |
| antigen processing and presentation of exogenous peptide antigen via mhc class i | GO:0042590 | 6 | 0.136 | |
| positive regulation of dendritic cell dendrite assembly | GO:2000549 | 1 | 0.136 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.135 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.135 | |
| activation of immune response | GO:0002253 | 138 | 0.134 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.133 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.132 | |
| cerebellar granular layer development | GO:0021681 | 13 | 0.131 | |
| glomerular visceral epithelial cell development | GO:0072015 | 6 | 0.129 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.124 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.120 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 32 | 0.120 | |
| lipid modification | GO:0030258 | 65 | 0.120 | |
| regulation of platelet derived growth factor receptor signaling pathway | GO:0010640 | 9 | 0.119 | |
| synapse organization | GO:0050808 | 125 | 0.119 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.118 | |
| metanephric glomerular epithelial cell differentiation | GO:0072312 | 2 | 0.118 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.117 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.117 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.115 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.115 | |
| granulocyte macrophage colony stimulating factor biosynthetic process | GO:0042253 | 2 | 0.114 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.113 | |
| renal filtration cell differentiation | GO:0061318 | 10 | 0.112 | |
| renal system development | GO:0072001 | 225 | 0.111 | |
| cell cell adhesion | GO:0098609 | 41 | 0.110 | |
| maintenance of location | GO:0051235 | 89 | 0.110 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.109 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.106 | |
| regulation of mast cell activation | GO:0033003 | 21 | 0.105 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.104 | |
| kidney development | GO:0001822 | 213 | 0.104 | |
| cytokine production | GO:0001816 | 319 | 0.103 | |
| antigen processing and presentation of exogenous peptide antigen | GO:0002478 | 21 | 0.103 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.102 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.101 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.100 | |
| g protein coupled purinergic nucleotide receptor signaling pathway | GO:0035589 | 1 | 0.100 | |
| heterophilic cell cell adhesion via plasma membrane cell adhesion molecules | GO:0007157 | 20 | 0.099 | |
| positive regulation of type ii hypersensitivity | GO:0002894 | 4 | 0.099 | |
| cerebellar granule cell differentiation | GO:0021707 | 9 | 0.098 | |
| immunoglobulin production in mucosal tissue | GO:0002426 | 3 | 0.098 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.098 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.097 | |
| regulation of protein transport | GO:0051223 | 163 | 0.097 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.097 | |
| fat cell differentiation | GO:0045444 | 160 | 0.096 | |
| positive regulation of synapse assembly | GO:0051965 | 18 | 0.096 | |
| positive regulation of type iii hypersensitivity | GO:0001805 | 3 | 0.096 | |
| glucose transport | GO:0015758 | 56 | 0.095 | |
| positive regulation of glomerulus development | GO:0090193 | 5 | 0.094 | |
| cell chemotaxis | GO:0060326 | 81 | 0.094 | Human |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.094 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.093 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.093 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.093 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.093 | |
| regulation of renal albumin absorption | GO:2000532 | 1 | 0.092 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.092 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.091 | |
| membrane invagination | GO:0010324 | 17 | 0.091 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.091 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.090 | |
| cell adhesion | GO:0007155 | 329 | 0.090 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.090 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.089 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.089 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.088 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.087 | |
| humoral immune response | GO:0006959 | 57 | 0.087 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.087 | |
| toxin catabolic process | GO:0009407 | 1 | 0.085 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.085 | Rat |
| cell migration involved in kidney development | GO:0035787 | 3 | 0.085 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.085 | |
| regulation of secretion | GO:0051046 | 274 | 0.085 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.084 | |
| myeloid cell activation involved in immune response | GO:0002275 | 34 | 0.084 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.084 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.083 | |
| renal protein absorption | GO:0097017 | 1 | 0.083 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.083 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.081 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.081 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.080 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.079 | |
| regulated secretory pathway | GO:0045055 | 32 | 0.079 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.079 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.078 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.077 | |
| glomerulus development | GO:0032835 | 40 | 0.077 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.077 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.076 | Human |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.076 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.076 | |
| defense response to other organism | GO:0098542 | 197 | 0.075 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.075 | Human |
| regulation of defense response | GO:0031347 | 233 | 0.075 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.073 | |
| glomerular epithelial cell development | GO:0072310 | 6 | 0.073 | |
| cell differentiation involved in metanephros development | GO:0072202 | 12 | 0.073 | |
| fatty acid derivative biosynthetic process | GO:1901570 | 15 | 0.072 | |
| adaptive immune response | GO:0002250 | 155 | 0.071 | |
| leukotriene metabolic process | GO:0006691 | 7 | 0.071 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.071 | |
| regulation of type ii hypersensitivity | GO:0002892 | 4 | 0.071 | |
| fc epsilon receptor signaling pathway | GO:0038095 | 3 | 0.069 | |
| exocytosis | GO:0006887 | 121 | 0.069 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.069 | |
| regulation of epithelial cell differentiation involved in kidney development | GO:2000696 | 10 | 0.068 | |
| hexose transport | GO:0008645 | 56 | 0.067 | |
| regulation of type iii hypersensitivity | GO:0001803 | 3 | 0.067 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.067 | |
| negative regulation of inflammatory response to antigenic stimulus | GO:0002862 | 10 | 0.066 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.065 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.065 | |
| mast cell activation | GO:0045576 | 27 | 0.064 | |
| negative regulation of metanephros development | GO:0072217 | 6 | 0.064 | |
| ear development | GO:0043583 | 200 | 0.064 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.063 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.063 | |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.062 | |
| carbohydrate transport | GO:0008643 | 62 | 0.062 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.062 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.062 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.062 | |
| eosinophil migration | GO:0072677 | 3 | 0.061 | |
| negative regulation of cellular carbohydrate metabolic process | GO:0010677 | 19 | 0.061 | |
| unsaturated fatty acid biosynthetic process | GO:0006636 | 15 | 0.061 | |
| interleukin 3 production | GO:0032632 | 3 | 0.061 | |
| mast cell degranulation | GO:0043303 | 19 | 0.061 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.061 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.060 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.060 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.060 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.060 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.059 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.059 | |
| glucose import | GO:0046323 | 32 | 0.059 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.058 | Human Rat |
| activation of mapk activity | GO:0000187 | 59 | 0.058 | |
| monosaccharide transport | GO:0015749 | 58 | 0.058 | |
| toll like receptor 7 signaling pathway | GO:0034154 | 4 | 0.058 | |
| regulation of cell motility | GO:2000145 | 236 | 0.057 | Human Rat |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.057 | |
| negative regulation of metanephric mesenchymal cell migration | GO:2000590 | 1 | 0.057 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.057 | |
| regulation of natural killer cell activation | GO:0032814 | 22 | 0.057 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.056 | |
| negative regulation of platelet derived growth factor receptor alpha signaling pathway | GO:2000584 | 2 | 0.056 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.056 | |
| activation of jun kinase activity | GO:0007257 | 15 | 0.056 | |
| cerebellum development | GO:0021549 | 77 | 0.056 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.055 | |
| cell junction maintenance | GO:0034331 | 4 | 0.055 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.055 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.055 | |
| regulation of adiponectin secretion | GO:0070163 | 2 | 0.054 | |
| endocytosis | GO:0006897 | 168 | 0.054 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.053 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.053 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.053 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.053 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.052 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.052 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.052 | |
| regulation of ion transport | GO:0043269 | 215 | 0.052 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.052 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 8 | 0.051 | |
| antigen processing and presentation of peptide antigen via mhc class i | GO:0002474 | 9 | 0.051 | |
| positive regulation of immunoglobulin production in mucosal tissue | GO:2000558 | 1 | 0.051 | |
| regulation of system process | GO:0044057 | 200 | 0.051 | Rat |
| lipid oxidation | GO:0034440 | 29 | 0.051 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.050 | |
| myotube differentiation | GO:0014902 | 105 | 0.050 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.050 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.049 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.049 | Human |
| positive regulation of glucose transport | GO:0010828 | 16 | 0.049 | |
| inflammatory response | GO:0006954 | 244 | 0.049 | Rat |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.049 | |
| positive regulation of epithelial cell differentiation involved in kidney development | GO:2000698 | 2 | 0.049 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.048 | |
| oxidation reduction process | GO:0055114 | 342 | 0.048 | |
| metanephros development | GO:0001656 | 79 | 0.048 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.048 | |
| negative regulation of t cell proliferation | GO:0042130 | 38 | 0.047 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.047 | |
| cytokine secretion | GO:0050663 | 72 | 0.047 | |
| nephron development | GO:0072006 | 109 | 0.047 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.047 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.047 | Human |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.046 | |
| negative regulation of adaptive immune response | GO:0002820 | 25 | 0.046 | |
| regulation of toll like receptor 9 signaling pathway | GO:0034163 | 3 | 0.046 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.045 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.045 | Rat |
| adiponectin secretion | GO:0070162 | 2 | 0.045 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.045 | Human |
| positive regulation of camp dependent protein kinase activity | GO:2000481 | 3 | 0.045 | |
| nephron epithelium development | GO:0072009 | 92 | 0.045 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.044 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.044 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.044 | |
| fatty acid oxidation | GO:0019395 | 28 | 0.044 | |
| metencephalon development | GO:0022037 | 89 | 0.044 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.044 | |
| regulation of type i hypersensitivity | GO:0001810 | 4 | 0.043 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.043 | |
| developmental maturation | GO:0021700 | 193 | 0.043 | |
| spermatogenesis | GO:0007283 | 284 | 0.043 | |
| regulation of glucose transport | GO:0010827 | 32 | 0.042 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.042 | |
| t cell activation | GO:0042110 | 289 | 0.042 | Human |
| cd4 positive alpha beta t cell cytokine production | GO:0035743 | 4 | 0.042 | |
| antigen processing and presentation of peptide antigen via mhc class ii | GO:0002495 | 17 | 0.042 | |
| axonogenesis | GO:0007409 | 274 | 0.042 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.041 | |
| cerebellar granular layer formation | GO:0021684 | 9 | 0.041 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 31 | 0.041 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.041 | |
| regulation of toll like receptor 4 signaling pathway | GO:0034143 | 4 | 0.041 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.041 | |
| regulation of eosinophil migration | GO:2000416 | 2 | 0.040 | |
| innate immune response | GO:0045087 | 157 | 0.040 | Human Rat |
| positive regulation of monocyte chemotaxis | GO:0090026 | 2 | 0.040 | Human |
| blood coagulation | GO:0007596 | 76 | 0.040 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.040 | |
| regulation of inflammatory response to antigenic stimulus | GO:0002861 | 21 | 0.040 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.040 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.040 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.039 | |
| regulation of b cell chemotaxis | GO:2000537 | 2 | 0.039 | |
| regulation of protein localization | GO:0032880 | 231 | 0.039 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.039 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.039 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.039 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.038 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.038 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.038 | |
| epithelial cell differentiation involved in kidney development | GO:0035850 | 23 | 0.038 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.038 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.038 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.038 | |
| b cell activation | GO:0042113 | 161 | 0.038 | |
| regulation of natural killer cell chemotaxis | GO:2000501 | 1 | 0.038 | |
| b cell receptor signaling pathway | GO:0050853 | 20 | 0.038 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.037 | |
| sensory perception | GO:0007600 | 245 | 0.037 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.037 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.037 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.037 | |
| positive regulation of renal albumin absorption | GO:2000534 | 1 | 0.037 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.036 | |
| glucose metabolic process | GO:0006006 | 92 | 0.036 | |
| positive regulation of type iia hypersensitivity | GO:0001798 | 4 | 0.036 | |
| defense response to bacterium | GO:0042742 | 119 | 0.036 | |
| dendritic cell differentiation | GO:0097028 | 26 | 0.036 | |
| male gamete generation | GO:0048232 | 285 | 0.036 | |
| metanephric nephron development | GO:0072210 | 34 | 0.036 | |
| hormone secretion | GO:0046879 | 128 | 0.036 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.036 | |
| regulation of t helper 1 cell cytokine production | GO:2000554 | 1 | 0.035 | |
| mast cell mediated immunity | GO:0002448 | 20 | 0.035 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.035 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.035 | |
| glucose homeostasis | GO:0042593 | 128 | 0.035 | |
| l amino acid transport | GO:0015807 | 32 | 0.035 | |
| macrophage migration inhibitory factor signaling pathway | GO:0035691 | 2 | 0.035 | |
| basal protein localization | GO:0045175 | 1 | 0.035 | |
| fatty acid beta oxidation | GO:0006635 | 16 | 0.035 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.034 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.034 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.033 | |
| positive regulation of myeloid leukocyte mediated immunity | GO:0002888 | 14 | 0.033 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.033 | Human Rat |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.033 | |
| glomerular epithelial cell differentiation | GO:0072311 | 10 | 0.033 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.033 | |
| muscle cell development | GO:0055001 | 133 | 0.033 | |
| natural killer cell chemotaxis | GO:0035747 | 1 | 0.033 | |
| cerebellar cortex formation | GO:0021697 | 22 | 0.033 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.032 | |
| response to growth factor | GO:0070848 | 198 | 0.032 | |
| negative regulation of granulocyte differentiation | GO:0030853 | 3 | 0.032 | |
| muscle tissue development | GO:0060537 | 308 | 0.032 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.032 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.032 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.032 | |
| positive regulation of glucose import | GO:0046326 | 14 | 0.031 | |
| metanephric nephron epithelium development | GO:0072243 | 19 | 0.031 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.031 | |
| positive regulation of jun kinase activity | GO:0043507 | 30 | 0.031 | |
| response to peptide hormone | GO:0043434 | 127 | 0.031 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.031 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.031 | |
| negative regulation of phospholipase activity | GO:0010519 | 4 | 0.031 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.031 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.030 | |
| cerebellar cortex morphogenesis | GO:0021696 | 32 | 0.030 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.030 | |
| regulation of glomerulus development | GO:0090192 | 6 | 0.029 | |
| regionalization | GO:0003002 | 337 | 0.029 | |
| negative regulation of humoral immune response mediated by circulating immunoglobulin | GO:0002924 | 3 | 0.029 | |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.029 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.029 | Rat |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.028 | |
| protein heterooligomerization | GO:0051291 | 14 | 0.028 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.028 | |
| regulation of t helper 2 cell cytokine production | GO:2000551 | 3 | 0.028 | |
| lipid catabolic process | GO:0016042 | 69 | 0.028 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.028 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.027 | |
| thymocyte migration | GO:0072679 | 2 | 0.027 | |
| positive regulation of tumor necrosis factor production | GO:0032760 | 30 | 0.027 | |
| negative regulation of platelet derived growth factor receptor signaling pathway | GO:0010642 | 7 | 0.027 | |
| response to monosaccharide | GO:0034284 | 67 | 0.027 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.027 | |
| kidney epithelium development | GO:0072073 | 121 | 0.027 | |
| antibody dependent cellular cytotoxicity | GO:0001788 | 2 | 0.027 | |
| positive regulation of immunoglobulin mediated immune response | GO:0002891 | 26 | 0.026 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.026 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.026 | |
| neutrophil chemotaxis | GO:0030593 | 36 | 0.026 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.026 | |
| gtp catabolic process | GO:0006184 | 143 | 0.026 | |
| myotube cell development | GO:0014904 | 60 | 0.026 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.026 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.026 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.026 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.026 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.026 | Human |
| positive regulation of neuron death | GO:1901216 | 28 | 0.025 | |
| regulation of humoral immune response mediated by circulating immunoglobulin | GO:0002923 | 10 | 0.025 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.025 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.025 | Human |
| mitotic cell cycle process | GO:1903047 | 159 | 0.025 | Human |
| positive regulation of dna biosynthetic process | GO:2000573 | 4 | 0.025 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.025 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.025 | Human |
| astrocyte cell migration | GO:0043615 | 3 | 0.025 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.025 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.025 | |
| regulation of mast cell activation involved in immune response | GO:0033006 | 17 | 0.025 | |
| regulation of osteoclast differentiation | GO:0045670 | 36 | 0.025 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.025 | |
| regulation of humoral immune response | GO:0002920 | 22 | 0.025 | |
| synapse assembly | GO:0007416 | 56 | 0.025 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.025 | Human |
| granulocyte migration | GO:0097530 | 43 | 0.025 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.025 | |
| regulation of immunoglobulin production in mucosal tissue | GO:2000557 | 1 | 0.024 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.024 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.024 | |
| response to oxidative stress | GO:0006979 | 123 | 0.024 | Rat |
| cell recognition | GO:0008037 | 83 | 0.024 | |
| positive regulation of leukocyte degranulation | GO:0043302 | 10 | 0.024 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.024 | |
| b cell chemotaxis | GO:0035754 | 3 | 0.024 | |
| t cell differentiation | GO:0030217 | 174 | 0.024 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.024 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.024 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.024 | |
| lysosome localization | GO:0032418 | 20 | 0.024 | |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.024 | |
| organelle assembly | GO:0070925 | 177 | 0.024 | |
| hypersensitivity | GO:0002524 | 10 | 0.024 | |
| complement activation classical pathway | GO:0006958 | 2 | 0.024 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.023 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.023 | |
| regulation of metanephric glomerular visceral epithelial cell development | GO:2000477 | 1 | 0.023 | |
| negative regulation of leukocyte mediated immunity | GO:0002704 | 29 | 0.023 | |
| regulation of dendritic cell dendrite assembly | GO:2000547 | 2 | 0.023 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.023 | |
| negative regulation of erk1 and erk2 cascade | GO:0070373 | 21 | 0.023 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.023 | Human |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.023 | |
| hindbrain development | GO:0030902 | 128 | 0.022 | |
| regulation of myeloid leukocyte mediated immunity | GO:0002886 | 25 | 0.022 | |
| interleukin 12 secretion | GO:0072610 | 3 | 0.022 | |
| toll like receptor 9 signaling pathway | GO:0034162 | 6 | 0.022 | |
| urogenital system development | GO:0001655 | 261 | 0.022 | |
| positive regulation of adiponectin secretion | GO:0070165 | 1 | 0.022 | |
| response to insulin | GO:0032868 | 100 | 0.022 | |
| striated muscle cell development | GO:0055002 | 125 | 0.022 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.022 | |
| neuron death | GO:0070997 | 154 | 0.022 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.022 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.022 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.022 | |
| positive regulation of kidney development | GO:0090184 | 28 | 0.022 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.022 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.021 | |
| actin filament organization | GO:0007015 | 113 | 0.021 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.021 | |
| antigen processing and presentation of exogenous antigen | GO:0019884 | 26 | 0.021 | |
| jnk cascade | GO:0007254 | 72 | 0.021 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.021 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.021 | |
| melanocyte migration | GO:0097324 | 2 | 0.021 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.021 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.021 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.021 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.021 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.021 | |
| positive regulation of t helper 1 cell differentiation | GO:0045627 | 4 | 0.021 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.021 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.021 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.021 | |
| regulation of metanephros development | GO:0072215 | 15 | 0.021 | |
| metanephric epithelium development | GO:0072207 | 21 | 0.021 | |
| dendritic cell dendrite assembly | GO:0097026 | 2 | 0.021 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.020 | |
| regulation of thymocyte migration | GO:2000410 | 2 | 0.020 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.020 | |
| regulation of kidney development | GO:0090183 | 40 | 0.020 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.020 | |
| positive regulation of exocytosis | GO:0045921 | 20 | 0.020 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.020 | Human |
| cell cell junction organization | GO:0045216 | 72 | 0.020 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.020 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.020 | Rat |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.020 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.020 | |
